AstraZeneca-Gilead Deal to Face Political, Strategic Hurdles

(Bloomberg) -- A merger of drugmakers AstraZeneca Plc and Gilead Sciences Inc. is unlikely, according to analysts, after Bloomberg News reported that the U.K. company made a preliminary approach to...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.